A detailed history of Ieq Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 5,334 shares of REGN stock, worth $3.81 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,334
Previous 5,531 3.56%
Holding current value
$3.81 Million
Previous $5.81 Million 3.54%
% of portfolio
0.07%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $201,745 - $236,746
-197 Reduced 3.56%
5,334 $5.61 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $447,782 - $543,093
507 Added 10.09%
5,531 $5.81 Million
Q1 2024

May 08, 2024

BUY
$902.69 - $993.35 $528,073 - $581,109
585 Added 13.18%
5,024 $4.84 Million
Q4 2023

Feb 07, 2024

BUY
$775.18 - $881.7 $767,428 - $872,883
990 Added 28.7%
4,439 $3.9 Million
Q3 2023

Nov 03, 2023

BUY
$692.45 - $844.37 $71,322 - $86,970
103 Added 3.08%
3,449 $2.84 Million
Q2 2023

Aug 07, 2023

BUY
$700.03 - $830.35 $51,102 - $60,615
73 Added 2.23%
3,346 $2.4 Million
Q1 2023

May 01, 2023

SELL
$680.49 - $826.97 $203,466 - $247,264
-299 Reduced 8.37%
3,273 $2.69 Million
Q4 2022

Feb 03, 2023

BUY
$705.89 - $766.39 $237,179 - $257,507
336 Added 10.38%
3,572 $2.58 Million
Q3 2022

Nov 03, 2022

BUY
$573.97 - $724.32 $427,033 - $538,894
744 Added 29.86%
3,236 $2.23 Million
Q2 2022

Jul 27, 2022

BUY
$548.35 - $738.84 $177,665 - $239,384
324 Added 14.94%
2,492 $1.47 Million
Q1 2022

Apr 26, 2022

BUY
$595.12 - $698.43 $242,213 - $284,261
407 Added 23.11%
2,168 $1.51 Million
Q4 2021

Jan 31, 2022

SELL
$543.48 - $670.97 $34,239 - $42,271
-63 Reduced 3.45%
1,761 $1.11 Million
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $470,130 - $557,706
819 Added 81.49%
1,824 $1.1 Million
Q2 2021

Jul 29, 2021

BUY
$472.8 - $558.54 $201,885 - $238,496
427 Added 73.88%
1,005 $561,000
Q1 2021

May 04, 2021

BUY
$446.73 - $548.2 $258,209 - $316,859
578 New
578 $273,000
Q4 2020

Feb 03, 2021

SELL
$478.3 - $607.98 $366,856 - $466,320
-767 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$544.75 - $658.21 $544 - $658
1 Added 0.13%
767 $429,000
Q1 2020

May 07, 2020

BUY
$336.18 - $494.43 $31,600 - $46,476
94 Added 13.99%
766 $373,000
Q4 2019

Feb 11, 2020

BUY
$274.13 - $376.51 $184,215 - $253,014
672 New
672 $253,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.